A Novel Technology-assisted Home Based Aerobic Exercise Programme for Individuals With Parkinson's Disease
A Randomised Controlled Feasibility Study of a Novel Technology-assisted Home Based Aerobic Exercise Programme for Individuals With Parkinson's Disease
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aim to evaluate the (1) feasibility of a novel mobile application ( Combat PD) that support a home-based gamified aerobic exercise program in individuals with mild Parkinson's disease (PD). The study aims to further explore (2) the effectiveness of Combat PD in improving adherence to prescribed home-based exercise program; and (3) the clinical effectiveness if combat PD in improving motor and non-motor function in PD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2023
CompletedStudy Start
First participant enrolled
February 11, 2023
CompletedFirst Posted
Study publicly available on registry
February 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFebruary 21, 2023
February 1, 2023
1.4 years
February 9, 2023
February 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Adherence to exercise program
actual exercise frequency compared to prescribed exercise targets.
12 weeks
Adherence to exercise program
actual exercise duration compared to prescribed exercise targets.
12 weeks
Adherence to exercise program
actual exercise intensity (period of exercise performed within prescribed heart rate zone), compared to prescribed exercise targets.
12 weeks
Secondary Outcomes (10)
Adverse events
12 weeks
Motor section of Movement Disorder Society sponsored Unified Parkinson's disease Rating Scale (MDS-UPDRS-III)
12 weeks
Timed Up and Go test (TUG)
12 weeks
Dual-task Timed Up and Go Test (TUG)
12 weeks
6-minute walk test
12 weeks
- +5 more secondary outcomes
Study Arms (2)
Combat PD
EXPERIMENTALCombat PD is an aerobic exercise programme hosted on a mobile application.
Usual Care
ACTIVE COMPARATORHome exercises based on a standard PD exercise booklet, consisting mainly of range of motion and stretching exercises
Interventions
CombatPD is an aerobic exercise programme hosted on a mobile application that pairs with motion sensors and heart rate monitor, which connects to a web-based portal for remote monitoring. The wearable sensors consist of (i) 2 motion sensors worn across one thigh and attached to an exercise ring which is held by the participant during the exergame and (ii) 1 heart rate sensor worn across the participant's chest. They will receive once weekly physiotherapy sessions at the study site for the first 4 weeks where they will be guided through the use of the CombatPD. Participants will be instructed to perform 2 sessions of 30-minute exergames in addition to a session of 30-minute brisk walking every week for 12 weeks at home. They will be instructed to exercise at a target heart rate zone at moderate intensity (i.e., 40% - 60% Heart Rate Reserve), which will be gradually increased.
Participants in the control group (usual care) will receive once weekly physiotherapy sessions for first 2 weeks and another session at week 6 where they will be taught home exercises based on a standard PD exercise booklet, consisting mainly of range of motion and stretching exercises , as well as brisk walking techniques. Participants in the control group will be instructed to perform these home exercises twice a week, in addition to a 30-minute brisk walk for 12 weeks.
Eligibility Criteria
You may qualify if:
- Aged 30-75, diagnosed with Parkinson's disease, with mild disease severity (Hoehn and Yahr stages I to II)
- Sedentary lifestyle
- Has a smart phone device
You may not qualify if:
- Uncontrolled hypertension, arrhythmia, or unstable cardiovascular status
- Poorly controlled diabetes mellitus
- Advanced kidney disease
- BMI \> 30
- Recent cerebrovascular event/ concussion/ fall in the last 6 months
- Significant cognitive impairment (MoCA\<21)
- Any other medical/orthopaedic/psychiatric condition that would interfere with ability to participate in the study
- No stable internet or smart device access
- Inability to fill up self-reported questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tan Tock Seng Hospitallead
- Singhealth Foundationcollaborator
Study Sites (1)
Tan Tock Seng Hospital
Singapore, 569766, Singapore
Related Publications (2)
Canning CG, Allen NE, Dean CM, Goh L, Fung VS. Home-based treadmill training for individuals with Parkinson's disease: a randomized controlled pilot trial. Clin Rehabil. 2012 Sep;26(9):817-26. doi: 10.1177/0269215511432652. Epub 2012 Jan 18.
PMID: 22257506BACKGROUNDvan der Kolk NM, de Vries NM, Penko AL, van der Vlugt M, Mulder AA, Post B, Alberts JL, Bloem BR. A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson's disease: results of a small randomised feasibility trial. J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):1003-1005. doi: 10.1136/jnnp-2017-315728. Epub 2017 Jun 12. No abstract available.
PMID: 28607121BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patient blinding will be done by ensuring that patients are unaware of the content of either treatment group before participation, and will only be made aware of the content of their allocated programme after randomization. They will be instructed not to share the details of their exercise programme with their physicians or other study participants, and to only contact their assigned physiotherapist in case of any problems during the study. Intervention and control group participants will be assigned different dates for study site visits to avoid cross-contamination. Study team members who will assess outcomes or perform data analyses will be masked to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Physiotherapist
Study Record Dates
First Submitted
February 9, 2023
First Posted
February 21, 2023
Study Start
February 11, 2023
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
February 21, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- 6 years after completion
- Access Criteria
- Researchers who provide a methodologically sound proposal
individual participant data that underlie the results reported, after deidentification